Dr. Levy to Present at First TREAT-NMD LGMD Masterclass in the US

Advancing Excellence in LGMD Diagnosis, Care, and Emerging Therapies (CME Accreditation)

📅 13-14 November 2026 | 📍 Atlanta, Georgia

As new therapies move closer to clinical practice, the need for accurate diagnosis, specialist knowledge, and coordinated multidisciplinary care has never been greater.

Developed for healthcare professionals involved in the diagnosis and management of limb-girdle muscular dystrophy (LGMD), this two-day Masterclass will deliver practical, expert-led education spanning the patient journey, from diagnosis through long-term care and emerging therapeutic developments.

Bringing together expert clinicians, therapists, and patient advocates from across North America, the program offers a valuable opportunity to learn from leaders in the field, exchange experiences and explore the latest advances shaping LGMD care. Dr. Jennifer Levy, C3 Scientific Director, will present “The Role of Registries and Developing Standards of Care.”

Topics Include

  • Diagnostic pathways and genetic testing
  • MRI and muscle biopsy in clinical practice
  • Standards of care and multidisciplinary management
  • Cardiac and respiratory considerations
  • Physiotherapy and rehabilitation
  • Clinical case discussions
  • Current and emerging therapies
  • Patient perspectives and advocacy

Who Should Attend?

This Masterclass is designed for:

  • Neurologists
  • Neuromuscular specialists
  • Geneticists
  • Rehabilitation physicians
  • Physiotherapists
  • Occupational therapists
  • Nurses and allied health professionals
  • Other healthcare professionals involved in LGMD care

Why Attend?

  • Gain practical insights you can apply directly to clinical practice
  • Learn from internationally recognised experts
  • Explore evolving diagnostic and therapeutic approaches
  • Take part in interactive case-based discussions
  • Connect with colleagues committed to improving outcomes for people living with LGMD

Join Us in Atlanta

This event is free of charge. Support for travel and accommodation may be available through an enablement fund for participants who would otherwise be unable to attend. If you would like to be considered for this support, please indicate this within your application.

The TREAT-NMD LGMD Masterclass North America represents a unique opportunity to strengthen expertise in a rapidly evolving area of neuromuscular medicine and contribute to better care for individuals living with LGMD.

CO-HOSTED BY TREAT-NMD & THE MUSCULAR DYSTROPHY ASSOCIATION

Recent Posts

  • Ruby Goldstein de Salazar Awarded C3 Travel Grant

    C3 awarded a Travel Grant to Ruby Goldstein de Salazar, a graduate student in Dr. Melissa Spencer’s laboratory at the University of California Los Angeles. Ms. Goldstein de Salazar traveled to Hiroshima, Japan in September 2026 to present her research at the 31st annual Congress of the World Muscle Society. Ms. Goldstein de Salazar’s presentation,... Read More
  • Djunda Ratenan-Peltier Awarded C3 Travel Grant

    C3 is pleased to announce that Djunda Ratenan-Peltier was awarded a Travel Grant for the presentation of her research at the international conference New Directions in Biology and Disease of Skeletal Muscle, which took place from June 7 to 10, 2026 in Fort Lauderdale, Florida. Ms. Ratenan-Peltier is a PhD student in Life Sciences at... Read More